Cargando…

Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases

Autoimmune diseases are affected by complex pathophysiology involving multiple cell types, cytokines, antibodies and mimicking factors. Different drugs are used to improve these autoimmune responses, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antibodies, and small mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Zhiyong, Zeng, Liuting, He, Qi, Yang, Kailin, Xiang, Wang, Ren, Xiang, Deng, Ying, Chen, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552782/ https://www.ncbi.nlm.nih.gov/pubmed/37809072 http://dx.doi.org/10.3389/fimmu.2023.1150661

Ejemplares similares

Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials
por: Long, Zhiyong, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren’s Syndrome
por: Zeng, Liuting, et al.
Publicado: (2022)

Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis
por: Zeng, Liuting, et al.
Publicado: (2022)

Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials
por: Zeng, Liuting, et al.
Publicado: (2022)

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial
por: Zeng, Liuting, et al.
Publicado: (2022)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials
por: Zeng, Liuting, et al.
Publicado: (2022)

Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials
por: Long, Zhiyong, et al.
Publicado: (2023)

The Role of IgG4 in Autoimmunity and Rheumatic Diseases
por: Maslinska, Maria, et al.
Publicado: (2022)

A systematic review of the research progress of non-coding RNA in neuroinflammation and immune regulation in cerebral infarction/ischemia-reperfusion injury
por: Yang, Kailin, et al.
Publicado: (2022)

Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
por: Zeng, Liuting, et al.
Publicado: (2022)

Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis, and Ankylosing Spondylitis): A Systematic Review and Meta-Analysis of Randomized Controlled Trial
por: Zeng, Liuting, et al.
Publicado: (2022)

Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
por: Duvvuri, Bhargavi, et al.
Publicado: (2019)

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
por: Graßhoff, Hanna, et al.
Publicado: (2021)

Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology
por: Li, Jie, et al.
Publicado: (2019)

The Uses and Misuses of Multiplex Autoantibody Assays in Systemic Autoimmune Rheumatic Diseases
por: Satoh, Minoru, et al.
Publicado: (2015)

Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases)
por: Gremese, Elisa, et al.
Publicado: (2014)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
por: Lakota, Katja, et al.
Publicado: (2021)

Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway
por: Li, Guangrui, et al.
Publicado: (2018)

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review
por: Zeng, Jinsong, et al.
Publicado: (2023)

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases
por: Mijnheer, Gerdien, et al.
Publicado: (2019)

Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases
por: Zheng, Zihan, et al.
Publicado: (2022)

Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research
por: Yang, Kailin, et al.
Publicado: (2019)

Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model
por: Sun, Yue, et al.
Publicado: (2017)

Publisher Correction: Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research
por: Yang, Kailin, et al.
Publicado: (2020)

Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling
por: Lyu, Taibiao, et al.
Publicado: (2023)

A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia
por: Wang, Shuhua, et al.
Publicado: (2023)

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2022)

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
por: Tao, Jun, et al.
Publicado: (2021)

Frailty in Rheumatic Diseases
por: Motta, Francesca, et al.
Publicado: (2020)

Research progress on application of single-cell TCR/BCR sequencing technology to the tumor immune microenvironment, autoimmune diseases, and infectious diseases
por: He, Jinhua, et al.
Publicado: (2022)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)

Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine
por: Guilherme, Luiza, et al.
Publicado: (2013)

Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report
por: Zhang, Juan, et al.
Publicado: (2022)

Curcumin in Autoimmune and Rheumatic Diseases
por: Yang, Melissa, et al.
Publicado: (2019)

Evolution of COVID-19 in patients with autoimmune rheumatic diseases
por: Pang, Rongrong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p0u4ncri9ur7slshp5c18s0sg9